Identification and human exposure prediction of two aldehyde oxidase-mediated metabolites of a methylquinoline-containing drug candidate

References

• Acheampong AA, Chien D, Lam S, et al. (1996). Characterization of brimonidine metabolism with rat, rabbit, dog, monkey and human liver fractions and rabbit liver aldehyde oxidase. Xenobiotica 26:1035–55.
   PubMed Web of Science ®Google Scholar
• Dalvie D, Sun H, Xiang C, et al. (2012). Effect of structural variation on aldehyde oxidase-catalyzed oxidation of zoniporide. Drug Metab Dispos 40:1575–87.
   PubMed Web of Science ®Google Scholar
• Dalvie D, Xiang C, Kang P, et al. (2013). Interspecies variation in the metabolism of zoniporide by aldehyde oxidase. Xenobiotica 43:399–408.
   PubMed Web of Science ®Google Scholar
• Diamond S, Boer J, Maduskuie TP, et al. (2010). Species-specific metabolism of SGX523 by aldehyde oxidase and the toxicological implications. Drug Metab Dispos 38:1227–85.
   Web of Science ®Google Scholar
• Felsted RL, Chaykin S. (1967). N1-methylniconamide oxidation in a number of mammals. J Biol Chem 242:1274–9.
   PubMed Web of Science ®Google Scholar
• Garattini E, Fratelli M, Terao M. (2009). The mammalian aldehyde oxidase gene family. Hum Genomics 4:119–30.
   PubMedGoogle Scholar
• Garattini E, Terao M. (2012). The role of aldehyde oxidase in drug metabolism. Expert Opin Drug Metab Toxicol 8:487–503.
   PubMed Web of Science ®Google Scholar
• Ghafourian T, Rashidi MR. (2001). Quantitative study of the structural requirements of phthalazine/quinazoline derivatives for interaction with human liver aldehyde oxidase. Chem Pharm Bull 49:1066–71.
   PubMed Web of Science ®Google Scholar
• Hutzler JM, Cerny MA, Yang Y, et al. (2014). Cynomolgus monkey as a surrogate for human aldehyde oxidase metabolism of the EGFR inhibitor BIBX1382. Drug Metab Dispo 42:1751–60.
   PubMed Web of Science ®Google Scholar
• Jensen KG, Jacobsen A-M, Bundgaard C, et al. (2017). Lack of exposure in a first-in-man study due to aldehyde oxidase metabolism: Investigated by use of 14C-microdose, humanized mice, monkey pharmacokinetics, and in vitro methods. Drug Metab Dispos 45:68–75.
   PubMed Web of Science ®Google Scholar
• Levy RH, Lane EA, Guyot M, et al. (1983). Analysis of parent drug-metabolite relationship in the presence of an inducer. Application to the carbamazepine-clobazam interaction in normal man. Drug Metab Dispos 11:286–92.
   PubMed Web of Science ®Google Scholar
• Lolkema MP, Bohets HH, Arkenau H-T, et al. (2015). The c-Met tyrosine kinase inhibitor JNJ-38877605 causes renal toxicity through species-specific insoluble metabolite formation. Clin Cancer Res 21:2297–304.
   PubMed Web of Science ®Google Scholar
• Lutz JD, Fujioka Y, Isoherranen N. (2010). Rationalization and prediction of in vivo metabolite exposures: the role of metabolite kinetics, clearance predictions and in vitro parameters. Expert Opin Drug Metab Toxicol 6:1095–109.
   PubMed Web of Science ®Google Scholar
• Mendal RR. (2009). Cell biology of molybdenum. BioFactors 35:429–34.
   PubMed Web of Science ®Google Scholar
• Morrison RD, Blobaum AL, Byers FW. (2012). The role of aldehyde oxidase and xanthine oxidase in the biotransformation of a novel negative allosteric modulator of metabotropic glutamate receptor Subtype 5. Drug Metab Dispo 40:1834–45.
   PubMed Web of Science ®Google Scholar
• O’Hara F, Burns AC, Colins MR, et al. (2014). A simple litmus test for aldehyde oxidase metabolism of heteroarenes. J Med Chem 57:1616–20.
   PubMed Web of Science ®Google Scholar
• Obach RS. (1996). The importance of non-specific binding in in vitro matrices, its impact on enzyme kinetic studies of drug metabolism reactions, and implications for in vitro-in vivo correlations. Drug Metab Dispos 24:1047–9.
   PubMed Web of Science ®Google Scholar
• Obach RS. (1999). Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and non-specific binding to microsomes. Drug Metab Dispos 27:1350–9.
   PubMed Web of Science ®Google Scholar
• Patel IH, Levy RH, Trager WF. (1978). Pharmacokinetics of carbamazepine-10,11- epoxide before and after autoinduction in rhesus monkeys. J Pharmacol Exp Ther 206:607–13.
   PubMed Web of Science ®Google Scholar
• Pryde DC, Dalvie D, Hu Q, et al. (2010). Aldehyde oxidase: an enzyme of emerging importance in drug discovery. J Med Chem 53:8441–60.
   PubMed Web of Science ®Google Scholar
• Robertson IGC, Palmer BD, Officer M, et al. (1991). Cytosol mediated metabolism of the experimental antitumor agent acridine carboxamide to the 9-acridone derivative. Biochem Pharmacol 42:1879–84.
   PubMed Web of Science ®Google Scholar
• Sanoh S, Tayama Y, Sugihara K, et al. (2015). Significance of aldehyde oxidase during drug development: effects on drug metabolism, pharmacokinetics, toxicity, and efficacy. Drug Metab Pharmacokinet 30:52–63.
   PubMed Web of Science ®Google Scholar
• Stanulovic M, Chaykin S. (1971). Aldehyde oxidase: catalysis of the oxidation of N 1 -methylnicotinamide and pyridoxal. Arch Biochem Biophys 145:27–34.
   PubMed Web of Science ®Google Scholar
• Tang H, Hussain A, Leal M, et al. (2007). Interspecies prediction of human drug clearance based on scaling data from one or two animal species. Drug Metab Dispos 35:1886–93.
   PubMed Web of Science ®Google Scholar
• Tran T, Adam FM, Calo F, et al. (2009). Design and optimisation of potent gp120-CD4 inhibitors. Bioorg Med Chem Lett 19:5250–5.
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration (US FDA). (2016). Safety testing of drug metabolites, guidance for industry. Rockville (MD). Available from: https://www.fda.gov/downloads/Drugs/…/Guidances/ucm079266.pdf.
   Google Scholar
• Wilkinson DJ, Southall RL, Li M, et al. (2017). Minipig and human metabolism of aldehyde oxidase substrates: in vitro-in vivo comparison. Aaps J 19:1163–74.
   PubMed Web of Science ®Google Scholar
• Zientek M, Jiang Y, Youdim K, et al. (2010). In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase. Drug Metab Dispo 38:1322–7.
   PubMed Web of Science ®Google Scholar